COMPANY PROFILE

Collate

Explore full profile

Platform that use AI to create and streamline paperwork for diagnostic, medical device, and drug development companies

San Francisco, United StatesFounded 2025Health Tech & Medtech

Valuation $1–2.5B Last recorded · 2026

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Collate

An AI-powered platform designed to automate and streamline the creation of documentation for drug development, medical device, and diagnostic companies. The company's mission is to expedite the delivery of life-saving innovations to patients by reducing the time and resources spent on paperwork and document editing. By handling the labor-intensive documentation process, from concept to market, it allows life sciences companies to focus on innovation and discovery. The platform is aimed at a variety of data practitioners and is built to manage and ensure high-quality data assets.

Collate has secured $30 million in a seed funding round, which will support its growth and the development of its AI-powered solutions. The company's services are targeted at the life sciences industry, and it operates within the healthcare technology market, providing a unified platform for data discovery, observability, and governance.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2025
Headquarters: San Francisco, United States
Employees: 29
Open positions: 1
Dealroom signal: 95.3/100
Industry: Health
Sub-industry: Health Platform
Sector: Health Tech & Medtech, Document Management, Drug Development, Core AI, Health Diagnostics, Verified Unicorns and $1B Exits, Woman Founder, AI Applications
Technology: Artificial Intelligence
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Jun 2026	$95M	$1B	First Round · Conviction · Redpoint	↗
SEEDOther financing	Jan 2025	$30M	$100M	Y Combinator · First Round · Conviction · Redpoint	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Collate website traffic

Latest recorded traffic for Collate is 25K monthly website visits, up 262.3% over the last three months. Collate's team grew 625% over the past year.

Latest monthly visits25K 3-month web change+262.3% 1-year team growth+625%

Monthly website visitsJan 2025–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Customer Success ManagerSan Francisco, CA · CSM & Support · Aug 18, 2026 Product DesignerSan Francisco, CA · Design · Jul 12, 2026 GTM RecruiterSan Francisco, CA · CSM & Support · Jul 11, 2026 Product ManagerSan Francisco, CA · Business Development · Jul 11, 2026 Medical WriterSan Francisco, CA · Other · Jul 10, 2026

5 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OPOptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management	Oxford, United Kingdom	Operational	51	$30M	$23M
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational
ILiLoFAI and photonics platform for personalized drug discovery.	London, United Kingdom	Operational
NGNostos GenomicsPartners with genetic labs to transform data into insights and deliver faster, clearer diagnoses for genetic diseases	Berlin, Germany	Acquired
MMMachine MedicineUses computer vision to track activities, walking patterns, detect falls and early signs of disease	London, United Kingdom	Operational
NENeuroelectricsDeveloping a unique platform to treat brain dysfunction with cloud-based, personalized neuromodulation	Barcelona, Spain	Operational
AIAidentisOffers automated dental imaging solutions that improve dental practices specialized in Orthodontics and Diagnostics	Almaty, Kazakhstan	Operational
PAPeer AIProviding AI-powered medical writing tools to speed up drug development and make the world healthier	San Francisco, United States	Operational